Hauj lwm lawm

Kev tsis

Apalutamide CAS 956104-40-8, Non-steroidal anti-androgen tshuaj siv rau kev kho mob qog noj ntshav prostate. Apalutamide ua haujlwm los ntawm kev tiv thaiv cov tshuaj hormone Testosterone Qhib cov ntsiab lus los ntawm kev txhawb cov qog nqaij hlav cancer kom loj hlob. Nws kuj nce tus nqi ntawm kev tuag ntawm cov qog nqaij hlav cancer.

Apalutamide CAS 956104-40-8

Khoom: Apalutamide CAS 956104-40-8
Lwm Lub Npe: ARN-509; 4-(7-(6-cyano-5-(trifluoroMethyl)pyridin-3-yl)-8-oxo-6-thioxo{{8} }, 7-diazaspirooctan-5-yl)-2-fluoro-N-MethylbenzaMide; ARV-509; ARN509; ARN; Apalutamide (ARN{16}}); Apalutamide; Apalutamide API; Apalutamide; Cov neeg nruab nrab; 956104-40-8; 573762-62-6; 1950587-17-3; 120728-10-1;
Cov mis mos molecular: C₂₁H₁₅F₄N₅O₂S
Molecular hnyav: 477.43
CAS Nr.: 956104-40-8
EINECS Number: 807-449-9
MDL No.: MFCD22380626

Apalutamide, nrog CAS tus lej 956104-40-8, yog cov tshuaj siv hauv kev kho mob qog noj ntshav prostate. Nov yog qee qhov txiaj ntsig ntawm Apalutamide:

1. Kev Kho Mob Cancer Prostate: Apalutamide tau pom zoo rau kev kho mob qog noj ntshav hauv qee theem. Nws yog tshwj xeeb yog siv rau kev kho mob ntawm non-metastatic castration-resistant prostate cancer (nmCRPC), uas txhais tau hais tias tus mob cancer tseem tsis tau kis mus rau lwm qhov ntawm lub cev txawm tias kev kho tshuaj hormone (castration).

2. Kev ncua sijhawm Metastasis: Apalutamide tau pom tias muaj txiaj ntsig zoo hauv kev ncua kev kis tus kabmob prostate mus rau lwm qhov ntawm lub cev hauv cov neeg mob uas tsis yog-metastatic castration-resistant prostate cancer. Los ntawm kev ua kom qeeb ntawm qhov kev loj hlob ntawm tus kab mob, nws tuaj yeem muab cov neeg mob ncua sij hawm ua ntej tus mob qog noj ntshav ua metastatic.

3. Kev Txhim Kho Kev Txhim Kho-Free Survival: Kev kho Apalutamide tau pom tias muaj kev txhim kho hauv kev muaj sia nyob tsis muaj sia nyob rau cov neeg mob uas tsis yog-metastatic castration-resistant prostate cancer. Kev muaj sia nyob tsis muaj kev vam meej yog hais txog lub sijhawm ntev ntawm kev kho mob thaum mob qog noj ntshav tsis zoo zuj zus lossis kis mus.

4. Kev ncua sij hawm xav tau kev kho mob ntxiv: Apalutamide tuaj yeem pab ncua kev xav tau kev kho mob ntxiv, xws li tshuaj kho mob lossis kev kho hluav taws xob, hauv cov neeg mob uas tsis yog-metastatic castration-resistant prostate cancer. Los ntawm kev tswj tus kab mob zoo, nws muab cov neeg mob nrog lub sijhawm txuas ntxiv yam tsis tas yuav muaj kev cuam tshuam ntau dua.

1. Lub sijhawm them nyiaj

TT, LC

2. Hnub xa khoom

Sib tham tau

3. Kev ua lag luam

Middle East / Africa / Asia / South America / Europe

4. Qauv

Muaj
5. Cov qauv kev tswj hwm
YBH/JP

6. Daim ntawv pov thawj tsim nyog

Kev tso npe "A" raws li txoj cai ntawm cov khoom ntim khoom raw, Kev Ceeb Toom Kev Pom Zoo ntawm kev lag luam

7. Ntim me me specification

Pem hauv ntej pob: ib txheej polyethylene hnab thiab txhuas ntawv ci hnab.

Sab nrauv pob: fiber nruas.

Ntim qhov loj: 25 kg / nruas.

Peb Qhov Zoo

Peb muaj cov chaw ua haujlwm hauv Dubai thiab Is Nrias teb

peb muaj tus kheej txhim khu kev qha & Kev koom tes ntev & kev paub txog lub Hoobkas

Ntau yam khoom rau xaiv los ntawm Tuam Tshoj thiab Is Nrias teb

Peb tuaj yeem kho raws li koj xav tau

Peb tuaj yeem ua OEM & ODM

Peb tuaj yeem muab N-1 rau API

Apalutamide API CAS 956104-40-8 FAQ

Q: Puas yog apalutamide suav tias yog kws khomob?

A: Apalutamide tsis suav tias yog tshuaj khomob. Nws yog ib qho tshuaj antineoplastic uas yog nyob rau hauv chav kawm hu ua antiandrogen therapy. Thaum nws yog siv rau hauv kev kho mob qog noj ntshav, tshwj xeeb tshaj yog mob qog noj ntshav prostate, nws ua haujlwm los ntawm inhibiting kev loj hlob ntawm cov qog nqaij hlav cancer es tsis ncaj qha tawm tsam lawv zoo li cov tshuaj siv tshuaj khomob.

Q: Koj tuaj yeem nyob ntev npaum li cas ntawm apalutamide?

A: uas apalutamide yuav tsum tau txuas ntxiv mus txog rau thaum muaj kab mob kis los yog qhov tsis txaus ntseeg lossis tus neeg mob xaiv kom tsis txhob kho. kev kho mob nrog apalutamide yuav tsum txuas ntxiv lossis tsis tau teem sijhawm yuav tshwm sim tsawg kawg los ntawm qhov pib thib peb 4- txhua lub lim tiam ntawm kev kho mob.

Q: Cov tshuaj apalutamide siv rau dab tsi?

A: Apalutamide yog siv los kho qee yam mob qog noj ntshav prostate (mob qog noj ntshav hauv cov txiv neej uas pib hauv prostate [ib txiv neej caj pas]) thiab tau kis mus rau lwm qhov ntawm lub cev lossis tsis kis mus rau lwm qhov ntawm lub cev tab sis muaj tsis tau txais kev pab los ntawm lwm yam kev kho mob.

Q: Puas yog apalutamide txo PSA?

A: Cov ntsiab lus: Qhov kev tshawb fawb hauv ntiaj teb no tau pom tias qhov pib ntawm apalutamide cuam tshuam nrog qhov muaj feem yuav ua tiav ntau dua lossis sib npaug li 90% txo qis hauv PSA piv rau qhov pib ntawm enzalutamide. Ntxiv mus, qhov kev sib sib zog nqus PSA no tau pom tshwm sim ua ntej nrog kev kho apalutamide dua li nrog enzalutamide.

Q: Puas yog apalutamide ua rau cov plaub hau poob?

A: Cov plaub hau thinning.Koj cov plaub hau yuav thinner thaum koj noj qhov kev kho no. Qhov no feem ntau yog mob me.

Q: Dab tsi yog qhov zoo ntawm apalutamide?

A: Tom qab kev soj ntsuam nruab nrab ntawm ze li 4 xyoo hauv TITAN txoj kev tshawb fawb, kev tuag ntawm cov pab pawg apalutamide tau txo qis los ntawm 35% piv nrog cov placebo pawg (median OS, NR vs. 52.2 lub hlis; HR=0. 65, 95 % CI 0.53–{1{12}}}.79 p < 0.0001)

Q: Lub sijhawm zoo tshaj plaws ntawm hnub noj apalutamide yog dab tsi?

A: Koj noj apalutamide ib hnub ib zaug. Koj nqos lawv tag nrho nrog ib khob dej. Koj tuaj yeem nqa lawv nrog zaub mov lossis thaum noj mov. Koj tseem coj lawv mus ntev npaum li lawv pab thiab cov kev mob tshwm sim tsis zoo heev.

Cim npe nrov: apalutamide cas 956104-40-8, Tuam Tshoj apalutamide cas 956104-40-8 manufacturers, lwm tus neeg, Hoobkas